The forecast for pancreas malignant neoplasms mortality among males in Canada indicates a steady increase from 2024 to 2028. Starting from a base of 2.99 thousand deaths in 2024, the value is expected to escalate marginally each year, reaching 3.19 thousand deaths by 2028. Compared to the actual 2023 figures, this represents a consistent upward trend with annual increases of approximately 1.67%. Over the forecasted five-year period, the compound annual growth rate (CAGR) suggests an enduring incremental impact.
Future trends to monitor include potential advancements in medical treatment that may alter these forecasts, as well as demographic shifts and healthcare policies that could influence the mortality rates. Additionally, increased awareness, early detection, and prevention efforts could impact these predicted trends significantly.
